SCHEMBL4632725

SCHEMBL4632725

CCN(CCCOc1cccc(Nc2cc(C)nc3ccccc23)c1)c1ccccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
HTT P42858 1/20 0.57
LMNA P02545 3/20 0.45
NPC1 O15118 2/20 0.45
ABCB1 P08183 1/20 0.43
ABCG2 Q9UNQ0 1/20 0.43
KMT2A Q03164 3/20 0.42
MITF O75030 1/20 0.42
TP53 P04637 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 1/20 0.40
YES1 P07947 1/20 0.40
SRC P12931 1/20 0.40
POLB P06746 2/20 0.40
ACP1 P24666 1/20 0.40
GUSB P08236 1/20 0.40
MAPT P10636 1/20 0.40
MEN1 O00255 1/20 0.40
NCF1 P14598 2/20 0.40
SLC2A1 P11166 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633225 0.95 TSHR (0.58) TSHRHTTLMNANPC1ABCB1
SCHEMBL4632728 0.79 TSHR (0.59) TSHRHTTLMNANPC1ABCB1
SCHEMBL4825623 0.79 TSHR (0.70) TSHRHTTLMNANPC1ABCB1
SCHEMBL14279315 0.79 TSHR (0.70) TSHRHTTLMNANPC1ABCB1
SCHEMBL4832413 0.78 TSHR (0.66) TSHRHTTLMNANPC1ABCB1
SCHEMBL4832602 0.78 TSHR (0.69) TSHRHTTLMNANPC1ABCB1
SCHEMBL6331255 0.77 TSHR (0.61) TSHRHTTLMNANPC1ABCB1
SCHEMBL4631944 0.77 TSHR (0.61) TSHRHTTLMNANPC1ABCB1
SCHEMBL4633229 0.76 TSHR (0.60) TSHRHTTLMNANPC1ABCB1
SCHEMBL4633382 0.76 TSHR (0.62) TSHRHTTLMNANPC1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603884-A4 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC (US) 2008-05-28 EP claimed
EP-1603884-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2005-12-14 EP claimed
WO-2004078114-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-16 WO claimed
EP-1603884-A4 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC (US) 2008-05-28 EP disclosed
EP-1603884-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2005-12-14 EP disclosed
WO-2004078114-A2 PYRIDINE, PYRIMIDINE, QUINOLINE, QUINAZOLINE, AND NAPHTHALENE UROTENSIN-II RECEPTOR ANTAGONISTS. ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-16 WO disclosed